AI assistant
Sending…
NEOGENOMICS INC — Director's Dealing 2012
Oct 1, 2012
32227_dirs_2012-10-01_dec2bc9e-f6e5-44cb-8d77-c31f8ed19d94.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NGNM.OB)
CIK: 0001077183
Period of Report: 2012-09-28
Reporting Person: DENT MICHAEL T (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-09-28 | Common Stock | S | 75000 | $3.01 | Disposed | 1528050 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 34500 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $0.25 | 2014-08-04 | Common Stock (0) | 400000 | Direct |
More from NEOGENOMICS INC
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24